RT Journal Article
SR Electronic
T1 Prevalence of SARS-CoV-2 in household members and other close contacts of COVID-19 cases: a serologic study in canton of Vaud, Switzerland
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.27.20239244
DO 10.1101/2020.11.27.20239244
A1 Julien Dupraz
A1 Audrey Butty
A1 Olivier Duperrex
A1 Sandrine Estoppey
A1 Vincent Faivre
A1 Julien Thabard
A1 Claire Zuppinger
A1 Gilbert Greub
A1 Giuseppe Pantaleo
A1 Jérôme Pasquier
A1 Valentin Rousson
A1 Malik Egger
A1 Amélie Steiner-Dubuis
A1 Sophie Vassaux
A1 Eric Masserey
A1 Murielle Bochud
A1 Semira Gonseth Nusslé
A1 Valérie D’Acremont
YR 2020
UL http://medrxiv.org/content/early/2020/11/30/2020.11.27.20239244.abstract
AB Background Understanding community-based SARS-CoV-2 transmission is crucial to inform public health decisions. Research on SARS-CoV-2 transmission within households and other close settings using serological testing is scarce.Methods We invited COVID-19 cases diagnosed between February 27 and April 1, 2020 in canton of Vaud, Switzerland, to participate, along with household members and other close contacts. Anti-SARS-CoV-2 IgG antibodies were measured using a Luminex immunoassay. We estimated factors associated with serological status using generalized estimating equations.Findings Overall, 219 COVID-19 index cases, 302 household members, and 69 other close contacts participated between May 4 and June 27, 2020. More than half of household members (57·2%, 95%CI 49·7-64·3) had developed a serologic response to SARS-CoV-2, while 19·0% (95%CI 10·0-33·2) of other close contacts were seropositive. After adjusting for individual and household characteristics, infection risk was higher in household members aged 65 or more than in younger adults (aOR 3·63, 95%CI 1·05-12·60), and in those not strictly adhering to simple hygiene rules like hand washing (aOR 1·80, 95%CI 1·02-3·17). The risk was lower when more than 5 people outside home were met during the semi-confinement, compared to none (aOR 0·35, 95%CI 0·16-0·74). The individual risk of household members to be seropositive was lower in large households (22% less per each additional person).Interpretation We find that, during semi-confinement, household members of a COVID-19 case were at very high risk of getting infected, 3 times more than close contacts outside home. This highlights the need to provide clear messages on specific protective measures applicable at home. For elderly couples, who were especially at risk, providing them external support for daily basic activities is essential.Funding Center for Primary Care and Public Health (Unisanté), Canton of Vaud, Leenaards Foundation, Fondation pour l’Université de Lausanne. SerocoViD is part of Corona Immunitas coordinated by SSPH+.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was funded by the operating budget of the Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland, and by contributions of local health authorities (Department of Health and Social Action, Canton of Vaud) and the following Swiss non-profit institutions: Leenaards Foundation, Fondation pour l'Universite de Lausanne. SerocoViD is part of the national Corona Immunitas program coordinated by the Swiss School of Public Health Plus (SSPH+).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Cantonal Ethics Committee of Vaud, Switzerland (ID 2020-00887) approved the protocol.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOur data are accessible to researchers upon reasonable request for data sharing to the corresponding author.